Search

Displaying results 6591 - 6600 of 10000 in total
  1. Drug

    Quazolast

    go.drugbank.com/drugs/DB20975
    Experimental

    The usage of the INN stem '-zolast' in the name indicates that Quazolast is a leukotriene biosynthesis inhibitor. Quazolast has a monoisotopic molecular weight of 262.01 Da.

  2. Drug

    Triampyzine

    go.drugbank.com/drugs/DB21035
    Experimental

    The usage of the INN stem '-yzine' in the name indicates that Triampyzine is a diphenylmethyl piperazine derivative. Triampyzine has a monoisotopic molecular weight of 165.13 Da.

  3. Drug

    Sobuzoxane

    go.drugbank.com/drugs/DB21119
    Experimental

    The usage of the INN stem '-oxan(e)' in the name indicates that Sobuzoxane is a benzodioxane derivative. Sobuzoxane has a monoisotopic molecular weight of 514.23 Da.

  4. Drug

    Oxeclosporin

    go.drugbank.com/drugs/DB21134
    Experimental

    The usage of the INN stem '-(clo)sporin' in the name indicates that Oxeclosporin is a cyclosporine derivative. Oxeclosporin has a monoisotopic molecular weight of 1261.86 Da.

  5. Drug

    Chloracyzine

    go.drugbank.com/drugs/DB21232
    Experimental

    The usage of the INN stem '-yzine' in the name indicates that Chloracyzine is a diphenylmethyl piperazine derivative. Chloracyzine has a monoisotopic molecular weight of 360.11 Da.

  6. Drug

    TEL540-548

    go.drugbank.com/drugs/DB17461
    Investigational

    TEL540-548 is a recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT).

  7. Drug

    Seliforant

    go.drugbank.com/drugs/DB15220
    Investigational

    Seliforant is under investigation in clinical trial NCT01260753 (Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge).

  8. Drug

    Etamicastat

    go.drugbank.com/drugs/DB15288
    Investigational

    Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).

  9. Drug

    SPP1148

    go.drugbank.com/drugs/DB05203
    Experimental

    SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.

  10. Drug

    Betacetylmethadol

    go.drugbank.com/drugs/DB01522
    ExperimentalIllicit

    A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]